INDIAS biggest biopharmaceutical company Biocon Ltd, which is investing US$200 million (RM668 million) to make insulin in Johor, is joining hands with Chemical Company of Malaysia Bhd (CCM) to sell Insugen in Malaysia early next year.
To continue reading the rest of the article, click here